Application of gold nanoparticles for targeted therapy in cancer

Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Cancer is a major public health problem worldwide. Some of the key challenges in cancer are early detection, diagnosis, and targeted therapy. Most of the patients are usually diagnosed in the late stage of the disease causing immunity to therapeutic intervention. Another major challenge in the therapeutic intervention of cancer is the toxicity of the anti-cancer drugs. When administered, these drugs are not only toxic towards malignant cells, but also towards normal cells. Nanotechnology can play a pivotal role in changing the very foundation of cancer treatment and diagnosis. At the heart of the nanotechnology are the nanoparticles and they can be synthesized in different shapes and sizes with tailor able optoelectronic and physico-chemical properties. Due to very high surface area of these nanoparticles, a number of biomolecules can be loaded to create a nanobioconjugate with multifunctional capabilities. Such a bi-functional nanobioconjugate containing a targeting agent and a drug would lead to targeted delivery of the drug to the malignant cells with better therapeutic efficacy and with reduced systemic toxicity. In a similar fashion targeted delivery of an imaging agent could lead to early detection of cancer. The design and development of nanoparticles and its nanobioconjugates in conjunction with the development of genomics and proteomics to identify biomarkers raise exciting opportunities for personalized treatment. In this particular review, we have discussed application of gold nanoparticles (AuNPs) in cancer and the current standing with respect to nanotechnology.

Original languageEnglish (US)
Pages (from-to)99-132
Number of pages34
JournalJournal of Biomedical Nanotechnology
Volume4
Issue number2
DOIs
StatePublished - Jun 2008

Fingerprint

Gold
Nanoparticles
Nanotechnology
Early Detection of Cancer
Pharmaceutical Preparations
Toxicity
Neoplasms
Oncology
Poisons
Biomolecules
Biomarkers
Public health
Therapeutics
Medical problems
Optoelectronic devices
Chemical properties
Genomics
Imaging techniques
Proteomics
Immunity

Keywords

  • Cancer
  • Colloid
  • Drug delivery
  • Functionalization
  • Gold nanoparticles
  • Synthesis
  • Targeted therapy

ASJC Scopus subject areas

  • Materials Science(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

Application of gold nanoparticles for targeted therapy in cancer. / Patra, Chitta Ranjan; Bhattacharya, Resham; Mukhopadhyay, Debabrata; Mukherjee, Priyabrata.

In: Journal of Biomedical Nanotechnology, Vol. 4, No. 2, 06.2008, p. 99-132.

Research output: Contribution to journalArticle

Patra, Chitta Ranjan ; Bhattacharya, Resham ; Mukhopadhyay, Debabrata ; Mukherjee, Priyabrata. / Application of gold nanoparticles for targeted therapy in cancer. In: Journal of Biomedical Nanotechnology. 2008 ; Vol. 4, No. 2. pp. 99-132.
@article{f9bc8fd12ec34d418ae7766b5c824282,
title = "Application of gold nanoparticles for targeted therapy in cancer",
abstract = "Cancer is a major public health problem worldwide. Some of the key challenges in cancer are early detection, diagnosis, and targeted therapy. Most of the patients are usually diagnosed in the late stage of the disease causing immunity to therapeutic intervention. Another major challenge in the therapeutic intervention of cancer is the toxicity of the anti-cancer drugs. When administered, these drugs are not only toxic towards malignant cells, but also towards normal cells. Nanotechnology can play a pivotal role in changing the very foundation of cancer treatment and diagnosis. At the heart of the nanotechnology are the nanoparticles and they can be synthesized in different shapes and sizes with tailor able optoelectronic and physico-chemical properties. Due to very high surface area of these nanoparticles, a number of biomolecules can be loaded to create a nanobioconjugate with multifunctional capabilities. Such a bi-functional nanobioconjugate containing a targeting agent and a drug would lead to targeted delivery of the drug to the malignant cells with better therapeutic efficacy and with reduced systemic toxicity. In a similar fashion targeted delivery of an imaging agent could lead to early detection of cancer. The design and development of nanoparticles and its nanobioconjugates in conjunction with the development of genomics and proteomics to identify biomarkers raise exciting opportunities for personalized treatment. In this particular review, we have discussed application of gold nanoparticles (AuNPs) in cancer and the current standing with respect to nanotechnology.",
keywords = "Cancer, Colloid, Drug delivery, Functionalization, Gold nanoparticles, Synthesis, Targeted therapy",
author = "Patra, {Chitta Ranjan} and Resham Bhattacharya and Debabrata Mukhopadhyay and Priyabrata Mukherjee",
year = "2008",
month = "6",
doi = "10.1166/jbn.2008.016",
language = "English (US)",
volume = "4",
pages = "99--132",
journal = "Journal of Biomedical Nanotechnology",
issn = "1550-7033",
publisher = "American Scientific Publishers",
number = "2",

}

TY - JOUR

T1 - Application of gold nanoparticles for targeted therapy in cancer

AU - Patra, Chitta Ranjan

AU - Bhattacharya, Resham

AU - Mukhopadhyay, Debabrata

AU - Mukherjee, Priyabrata

PY - 2008/6

Y1 - 2008/6

N2 - Cancer is a major public health problem worldwide. Some of the key challenges in cancer are early detection, diagnosis, and targeted therapy. Most of the patients are usually diagnosed in the late stage of the disease causing immunity to therapeutic intervention. Another major challenge in the therapeutic intervention of cancer is the toxicity of the anti-cancer drugs. When administered, these drugs are not only toxic towards malignant cells, but also towards normal cells. Nanotechnology can play a pivotal role in changing the very foundation of cancer treatment and diagnosis. At the heart of the nanotechnology are the nanoparticles and they can be synthesized in different shapes and sizes with tailor able optoelectronic and physico-chemical properties. Due to very high surface area of these nanoparticles, a number of biomolecules can be loaded to create a nanobioconjugate with multifunctional capabilities. Such a bi-functional nanobioconjugate containing a targeting agent and a drug would lead to targeted delivery of the drug to the malignant cells with better therapeutic efficacy and with reduced systemic toxicity. In a similar fashion targeted delivery of an imaging agent could lead to early detection of cancer. The design and development of nanoparticles and its nanobioconjugates in conjunction with the development of genomics and proteomics to identify biomarkers raise exciting opportunities for personalized treatment. In this particular review, we have discussed application of gold nanoparticles (AuNPs) in cancer and the current standing with respect to nanotechnology.

AB - Cancer is a major public health problem worldwide. Some of the key challenges in cancer are early detection, diagnosis, and targeted therapy. Most of the patients are usually diagnosed in the late stage of the disease causing immunity to therapeutic intervention. Another major challenge in the therapeutic intervention of cancer is the toxicity of the anti-cancer drugs. When administered, these drugs are not only toxic towards malignant cells, but also towards normal cells. Nanotechnology can play a pivotal role in changing the very foundation of cancer treatment and diagnosis. At the heart of the nanotechnology are the nanoparticles and they can be synthesized in different shapes and sizes with tailor able optoelectronic and physico-chemical properties. Due to very high surface area of these nanoparticles, a number of biomolecules can be loaded to create a nanobioconjugate with multifunctional capabilities. Such a bi-functional nanobioconjugate containing a targeting agent and a drug would lead to targeted delivery of the drug to the malignant cells with better therapeutic efficacy and with reduced systemic toxicity. In a similar fashion targeted delivery of an imaging agent could lead to early detection of cancer. The design and development of nanoparticles and its nanobioconjugates in conjunction with the development of genomics and proteomics to identify biomarkers raise exciting opportunities for personalized treatment. In this particular review, we have discussed application of gold nanoparticles (AuNPs) in cancer and the current standing with respect to nanotechnology.

KW - Cancer

KW - Colloid

KW - Drug delivery

KW - Functionalization

KW - Gold nanoparticles

KW - Synthesis

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=58149091081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149091081&partnerID=8YFLogxK

U2 - 10.1166/jbn.2008.016

DO - 10.1166/jbn.2008.016

M3 - Article

AN - SCOPUS:58149091081

VL - 4

SP - 99

EP - 132

JO - Journal of Biomedical Nanotechnology

JF - Journal of Biomedical Nanotechnology

SN - 1550-7033

IS - 2

ER -